Difficulty: Easy

Average Score: 93%

Which of the following information would be appropriate to include when dispensing cyclophosphamide 50 mg capsules?

Rationale

Warning: Do not use if you are pregnant, plan to become pregnant or while breastfeeding.

Cyclophosphamide is a chemotherapy medication that poses significant risks during pregnancy and breastfeeding. It can cause harm to the developing fetus and has the potential to be excreted in breast milk, which could adversely affect a nursing infant.

A (Keep refrigerated) YOUR ANSWER

Cyclophosphamide does not require refrigeration; it is typically stored at room temperature. This choice is incorrect because it misrepresents the proper storage conditions for this medication, which can lead to confusion regarding its handling.

B (May cause drowsiness) YOUR ANSWER

While some medications can cause drowsiness, cyclophosphamide is not primarily known for this side effect. This statement is misleading in the context of cyclophosphamide, as it does not emphasize the more critical safety concerns associated with its use, particularly regarding pregnancy.

C (You should avoid prolonged or excessive exposure to direct and/or artificial sunlight while taking this medication) YOUR ANSWER

Although cyclophosphamide can increase sensitivity to sunlight, this warning is less critical than the pregnancy-related warning. The focus should be on the severe implications of using the drug during pregnancy rather than sun exposure, making this option less appropriate in this context.

Conclusion

When dispensing cyclophosphamide 50 mg capsules, the most vital information to communicate is the warning against use during pregnancy, planning for pregnancy, or while breastfeeding. This guidance is essential to prevent significant health risks to both the patient and the fetus or nursing child. Other safety information, while relevant, does not carry the same level of urgency or potential consequence in this scenario.

Related Questions

View all